Elevated serum S100A4 levels in patients with silicosis

G. lingli (Tangshan, China), H. Liu (Tangshan, China), X. Hao (Tangshan, China)

Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Session: New mechanistic insights into pulmonary fibrosis
Session type: Thematic Poster
Number: 2428
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. lingli (Tangshan, China), H. Liu (Tangshan, China), X. Hao (Tangshan, China). Elevated serum S100A4 levels in patients with silicosis. 2428

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High serum levels of YKL-40 in IPF
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008


Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

High serum periostin levels and the association with pulmonary tuberculosis
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018

Serum levels of TIMP-1 and TIMP-2 are elevated in patients with pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Determinants of serum leptin and adiponectin levels in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005

Serum lipid levels in patients with bronchiectasis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

CEA levels in the serum and induced sputum of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 324s
Year: 2005

Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 424s
Year: 2002

Lebrikizumab reduces serum periostin in asthma patients with elevated baseline periostin
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012

Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients
Source: Eur Respir J 2015; 45: 1482-1485
Year: 2015


Elevated levels of BALF galectin-9 in patients with interstitial pneumonia
Source: Annual Congress 2009 - Airways remodelling
Year: 2009

Significance of serum YKL-40, S100A8, S100A9, calprotectin, periostin and LRG1 levels in patients with newly diagnosed, controlled and uncontrolled asthma
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018



Elevated serum levels of oxidative stress biomarkers in patients with lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Serum levels of TGFβ and VEGF in lung cancer patients and healthy subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 43s
Year: 2004

Serum levels of sFas and sFasL during chemotherapy of lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 329s
Year: 2005

Serum neopterin and IL-6 as biomarkers in patients with COPD.
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017


An association between sarcoidosis and serum immunoglobulin levels
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


Serum and r32kd induced cytokine levels and expression in tuberculosis patients and contacts
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012